CODX

$1.46+$0.01 (+0.68%)live

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Market cap

$5.5M

4M shares

52-week range

$1.26 – $46.50

0% from low

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Exchange

NASDAQ

Change$-339.91

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$552400	+14.0%	$-12.15	$-12.15–$-12.15	—	1
2027	$17M	+3011.1%	$-12.00	$-12.00–$-12.00	—	1
2028	$59M	+245.4%	$-6.90	$-6.90–$-6.90	—	1
2029	$137M	+130.1%	$6.60	$6.60–$6.60	0.2×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-13	$-3.00	$-1.46	+51.3%
2026-05-14	$-3.75	$-4.06	-8.3%
2026-03-31	$-3.60	$-16.35	-354.2%
2025-11-13	$-5.71	$-4.80	+15.9%
2025-08-14	$-0.25	$-0.23	+8.0%
2025-05-08	$-0.33	$-0.24	+27.3%
2025-03-27	$-0.34	$-0.36	-5.9%
2024-11-07	$-0.33

DCF fair valuemodel estimate

Intrinsic value

$7.45

Price

$1.46

Implied upside

+410%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CODXCo-Diagnostics, Inc.	$1.49	+0.68%	$2M	—
ADGMAdagio Medical Holdings, Inc.	$0.69	-0.01%	$15M	—
AEMDAethlon Medical, Inc.	$2.93	-1.35%	$2M	—
ALURAllurion Technologies Inc.	$4.71	-14.27%	$5M	—
DWTXDogwood Therapeutics, Inc.	$1.98	+2.86%

Co-Diagnostics, Inc. Common Stock

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

www.codiagnostics.com

Employees: 115
IPO / List date: Jul 12, 2017
HQ: SALT LAKE CITY, UT

Held by traders on TradeandTell

No one on the platform currently holds CODX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CODX as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2026-01-02	1-for-30reverse

Recent trades on TradeandTell

No one on the platform has traded CODX yet.

$CODX chatter on StockTwits

CoffeeRocks@CoffeeRocksBullish1h
$CODX $AEMD $BTAI $VRAX $GOVX https://share.google/OJDYubJ7LmVHB0c0r
View on StockTwits ↗
Antiquarian@Antiquarian11h
$CODX I’m dying over here.
View on StockTwits ↗
Ark@Pyranha13h
$CODX very neutral earnings call today. No steep market reaction…. I remember this time 2 years ago…. Waiting on the FDA decision. Ofc I felt much better back then as they were soooo certain it would be approved and I dreamed of being 30x richer than I dream about today. Now I’m in limbo Wonder how the TB trials are doing. Would be nice for some metrics on how many tests they are running. Very poor show at the Q&A
View on StockTwits ↗
John Sullivan@BuyTheBook15h
$CODX I was listening to the Art Of Noise while working on my Greenhouse and totally forgot about the report and only caught the very tail end. What did I miss???
View on StockTwits ↗
London Says@LondonVentures15h
$CODX any butt cheeks clapping sounds happening in the background on this call?
View on StockTwits ↗
Nick@JustAsBadAsCasino15h
$CODX 🤨 wow..." and we thank our employees ((the ones not terminated in the cutt backs )) ..." and our shareholders " ...
View on StockTwits ↗
Millones@Millones15h
$CODX On July 28th, 2026 the parties entered into a binding term sheet setting forth the material terms of a proposed settlement of the Stadium Capital securities class action. Under the term sheet, the defendants (Co-Diagnostics) will pay, or cause to be paid, $6.5M into a settlement fund in exchange for the settlement and release of claims asserted.
View on StockTwits ↗
Todd Gaak@Tgaak15h
$CODX Expanded x2, hosted, expanded x2, initiated, strengthened = operational progress. All good things - show me the path to revenue. Investors have been waiting (too long) to follow that story Ike - I hope dilution is not part of that road.
View on StockTwits ↗
Macney@Rudder6415h
$CODX I wouldn't waste my time listening to these crooks.
View on StockTwits ↗
jorge .miguel@focafoca9915h
$CODX communicates its June-30, 2026 quarter results in a press release. https://www.rapidticker.com/news/codx-sec-filing-550d45
View on StockTwits ↗
Millones@Millones16h
$CODX The company has reported $3.6M of cash/equivalents….
View on StockTwits ↗
jean louis ropers@jlropers18h
$CODX on their web site , investment part , they have the audacity to put a investment simulation tool to help you calculate how much you lost buying their shares ! If you had put money in 2022, you only lost 99,47 % ! About my case ! They have no self respect https://ir.co-dx.com/investment-calculator
View on StockTwits ↗
London Says@LondonVentures19h
$CODX Who's ready to get bent over today after market?
View on StockTwits ↗
FilthyPeasant@FilthyPeasant19h
$CODX the calculus is that they're on the verge of commercializing in India where they need something like >30mm TB tests/yr. WHO invited them to an event about two months back to advertise their technology and solicit orders from national governments, with WHO support in submitting grant funding request for purchase orders! they could also choose to SPAC some of their 50% stake in India for cash if they desire. Then the real main course, FDA approval for ABR test, which should occur by Q4 and that's a $5B + market opportunity in North America. They're so close to generating cashflow and their burn is so light that the calculus, for me at least, is to position ahead of the final piece of the puzzle coming soon. Wouldn't be surprised to see more grant funding from the Gates Foundation, either. They have been to India last year to specifically visit this company's facilities. so many shills around this name, just like $SLS so watch out! my only cross-post, I promise! good luck everybody
View on StockTwits ↗
Millones@Millones20h
@jlropers @cnichter118 IMO, it’s never too late to buy $CODX If you wait, it’ll keep getting cheaper.
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.